Remove Generic Medicine Remove Pharmaceutical Manufacturing Remove Presentation
article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

FDA’s Emerging Technology Program “Advanced manufacturing as a concept, as an initiative, has been very important to the agency,” emphasized workshop presenter Adam Fisher, Ph.D., Director, Science Staff, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research (CDER), FDA.

article thumbnail

Manufacturing solutions are essential to strengthen the global medicines supply chain

Quality Matters

government’s fiscal 2023 funding bill , signed into law in December 2022, included a range of specific provisions to support medicines supply chain resilience, including those supporting development of AMT through creation of national centers of excellence. The non-profit maker of essential generic medicines was established by a group of U.S.

article thumbnail

How could tariffs impact the pharmaceutical industry?

European Pharmaceutical Review

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.